Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men

HIV Infections Clinical Trial

— online-RASSL  

Official title:

Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men in Beijing: a Social Media-based Randomized Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03320239
• Other study ID #: risk assessment
• Status: Recruiting
• Phase: N/A
• First received: October 17, 2017
• Last updated: October 20, 2017
• Start date: October 12, 2017
• Est. completion date: May 2018

Study information

• Verified date: October 2017
• Source: National Center for AIDS/STD Control and Prevention, China CDC
• Contact: Wu Z You, PhD
• Phone: 010-58900946
• Email: wuzy[@]263.net
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of the study is to evaluate the effectiveness of a HIV risk assessment tool to promote HIV testing and to reduce high risk sexual behaviors among men who have sex with men (MSM). It hypothesizes that the social media-based HIV risk assessment tool can increase 20% HIV testing proportion during the six months follow-up period.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 4500
• Est. completion date: May 2018
• Est. primary completion date: May 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Male at birth.

• Having had homo-sexual behaviors (anal/oral) in the past 6 months before enrollment.

• An age of 18 years or older.

• Living in Beijing, China.

• Self-reporting HIV negative or unknown.

• Willingly participating into the baseline survey and the six months follow ups.

• Agreeing not to share the research link to others.

• Owning a mobile phone and having had downloaded the social networking Application Blued before enrollment.

Exclusion Criteria:

• Not accepting blood sampling within the study period.

• Reporting injecting drugs use in the past six months before enrollment.

• Being currently involved in other HIV behavioral interventions for MSM.

• Having a specific plan to leave from Beijing in the next 6 months.

• Self-reporting female.

• Other reasons the investigators deem make participation either detrimental to the participants or the study.

Related Conditions & MeSH terms

• HIV Infections
• HIV/AIDS
• Social Media

Intervention

Behavioral:
• HIV risk assessment and tailored suggestions
The intervention contains: HIV risk investigation, tailored suggestions and free HIV testing link
• HIV risk behavior assessment
It only contains HIV risk behavior assessment and routine education
• placebo control
It only contains HIV/AIDS knowledge assessment and routine education

Locations

Country	Name	City	State
China	national center for AIDS control and prevention	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
National Center for AIDS/STD Control and Prevention, China CDC

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The proportion of HIV testing during the study period	The numerator is the number of participants who come to the specific HIV testing clinics for HIV test during the study period, the denominator is the number of participants randomized per group.	1 month
Secondary	unprotected anal intercourse	Questionaire will be used to collect the frequency of unprotected anal intercourse at month 1, month 3 and month 6 after the study starts.	6 months
Secondary	Post exposure prophylaxis (PEP)	Questionaire will be used to collect data on whether participants use PEP at month 1, month 3 and month 6.	6 months